Yishuang Xu

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Filter

2022
5MO Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase
Fontana, E., Lee, E., Rosen, E., Spigel, D., Højgaard, M., Lheureux, S., Mettu, N. B., Carter, L., Plummer, R., Manley, P., Ulanet, D., Rimkunas, V., Silverman, I. M., O'Connell, J., McDougall, R., Wainszelbaum, M., Xu, Y., Koehler, M., Fretland, A. J. & Yap, T. A., Mar 2022, p. S3-S4.
Research output: Contribution to conference › Abstract › peer-review

Research output